We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Commentary |

Challenging the Strategy of Maternal Age–Based Prenatal Genetic Counseling

Richard L. Berkowitz, MD; Jaclyn Roberts, MD; Howard Minkoff, MD
JAMA. 2006;295(12):1446-1448. doi:10.1001/jama.295.12.1446.
Text Size: A A A
Published online


The decision to offer pregnant women prenatal diagnosis for genetic diseases has long had an age-based trigger.1,2 Early studies convincingly demonstrated an escalating rate of aneuploidy with advancing maternal age,3 but risks related to amniocentesis are independent of maternal age. When the flat risk-line from the invasive diagnostic procedure (iatrogenic pregnancy loss) crossed the age-related ascending risk-line of aneuploidy on a graph of adverse events, an intersection was determined that became the age standard for offering the procedure. Data from the 1970s appeared to suggest that at the age of 35 years a woman had a similar chance of delivering a child with aneuploidy3 as experiencing a miscarriage after an amniocentesis,4 and that age became “the” prompt for genetic counseling.2 Much has been learned since then, but despite the substantially increased efficiency of diagnostic technologies and possibly reduced risks of procedure-related pregnancy loss,5 the recommendation remains unchanged. According to the current guidelines of the American College of Obstetricians and Gynecologists, “Women with singleton pregnancies who will be age 35 years or older at delivery should be offered prenatal diagnosis.”6 We suggest that advances in science and careful consideration of the ethics of testing should undermine any residual support for that standard.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

10 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles